#USA #Hartford #Connecticut #Generic Drugs #Settlement Funds

Allocation and Distribution Plan for Generic Drug Settlements

The Connecticut Attorney General's office has unveiled an Allocation and Distribution Plan aimed at compensating consumers affected by inflated prices for generic prescription drugs. This initiative stems from multiple legal settlements achieved with various generic drug manufacturers, following claims brought forth by the states’ attorneys general.

Background of the Lawsuits

From May 1, 2009, to December 31, 2019, consumers experienced overcharges for certain generic prescription medications. The lawsuits allege that these price increases were not justified and that consumers paid significantly higher amounts than warranted. In light of these findings, settlements with the involved manufacturers have been negotiated, directing funds toward consumer restitution.

Who Is Eligible for Compensation?

This plan specifically targets individuals who purchased the affected generic drugs within the specified time frame in the United States. Eligibility criteria require that individuals:

1. Have bought at least one of the designated drugs during the stated period.
2. Did not acquire these drugs for resale.
3. Are not affiliated with the defendant companies.
4. Reside in an eligible state, including those directly involved in the settlements or states such as Alabama, Arkansas, Hawaii, and Texas under specific conditions.

Benefits and Claims Process

Eligible consumers can select between two compensation options for each settlement:

• - Option 1: An equal share from the overall settlement.
• - Option 2: A share based on each individual's estimated out-of-pocket expenses on the drugs during the claim period.

Additionally, individuals in the aforementioned states may receive a fixed payment from the Apotex settlement funds specifically.

To participate, individuals must file a claim form by the deadline of March 8, 2027. Online submissions can be made at www.AGGenericdrugs.com or via mailed forms available on the same website. It is worth noting that no purchase receipts are necessary to file a claim, although estimates may be required for certain options.

Right to Object or Opt-Out

Consumers have the right to voice concerns or objections regarding the Distribution Plan until August 14, 2027. Those preferring to opt out entirely from the settlements must also submit their requests by this date.

For further details on the distribution plan, eligible drugs list, or any updates on the settlements, consumers are urged to visit www.AGGenericDrugs.com or contact their helpline at 1-866-290-0182.

Conclusion

By implementing this plan, the Connecticut Attorney General's office is making significant strides in addressing the financial burdens experienced by consumers due to unjust pricing practices in the pharmaceutical industry. With clear instructions for claiming compensation, affected individuals are encouraged to act promptly to secure the restitution they are entitled to.